

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | molting cycle (GO:0042303) | 8.24650785 |
| 2 | hair cycle (GO:0042633) | 8.24650785 |
| 3 | protein maturation by protein folding (GO:0022417) | 7.17441526 |
| 4 | extracellular fibril organization (GO:0043206) | 5.17774786 |
| 5 | response to gravity (GO:0009629) | 4.91403711 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.87859125 |
| 7 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.79087009 |
| 8 | pattern specification involved in kidney development (GO:0061004) | 4.71226264 |
| 9 | actin filament depolymerization (GO:0030042) | 4.70551785 |
| 10 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 4.61255767 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.60239505 |
| 12 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.59181139 |
| 13 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.45524632 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 4.40826468 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 4.40826468 |
| 16 | fibril organization (GO:0097435) | 4.22175728 |
| 17 | protein neddylation (GO:0045116) | 4.19048690 |
| 18 | maturation of 5.8S rRNA (GO:0000460) | 4.07153808 |
| 19 | substrate-dependent cell migration (GO:0006929) | 4.01392430 |
| 20 | ATP synthesis coupled proton transport (GO:0015986) | 3.99434517 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.99434517 |
| 22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.97143534 |
| 23 | establishment of integrated proviral latency (GO:0075713) | 3.95176226 |
| 24 | virion assembly (GO:0019068) | 3.89192923 |
| 25 | positive regulation of actin filament depolymerization (GO:0030836) | 3.87155687 |
| 26 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.86110724 |
| 27 | nuclear envelope reassembly (GO:0031468) | 3.84925382 |
| 28 | mitotic nuclear envelope reassembly (GO:0007084) | 3.84925382 |
| 29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.82169373 |
| 30 | type B pancreatic cell proliferation (GO:0044342) | 3.66900245 |
| 31 | mesodermal cell differentiation (GO:0048333) | 3.63363731 |
| 32 | muscle cell migration (GO:0014812) | 3.58921379 |
| 33 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.58251364 |
| 34 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.58080118 |
| 35 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.57605031 |
| 36 | viral protein processing (GO:0019082) | 3.55600375 |
| 37 | cellular response to vitamin (GO:0071295) | 3.53399649 |
| 38 | SMAD protein complex assembly (GO:0007183) | 3.53379609 |
| 39 | activated T cell proliferation (GO:0050798) | 3.51741984 |
| 40 | cell adhesion mediated by integrin (GO:0033627) | 3.50340889 |
| 41 | galactose catabolic process (GO:0019388) | 3.49668985 |
| 42 | termination of RNA polymerase III transcription (GO:0006386) | 3.42777618 |
| 43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.42777618 |
| 44 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.38006343 |
| 45 | centriole replication (GO:0007099) | 3.35977806 |
| 46 | chaperone-mediated protein transport (GO:0072321) | 3.35594497 |
| 47 | cellular response to exogenous dsRNA (GO:0071360) | 3.35081493 |
| 48 | ganglion development (GO:0061548) | 3.32896161 |
| 49 | proteasome assembly (GO:0043248) | 3.30004558 |
| 50 | hemidesmosome assembly (GO:0031581) | 3.27734202 |
| 51 | anterograde synaptic vesicle transport (GO:0048490) | 3.27053348 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.26009682 |
| 53 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.19761127 |
| 54 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.16410001 |
| 55 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.16410001 |
| 56 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.16410001 |
| 57 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.14973415 |
| 58 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.14973415 |
| 59 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.13343198 |
| 60 | regulation of mRNA splicing, via spliceosome (GO:0048024) | 3.09751999 |
| 61 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.09107872 |
| 62 | negative regulation of macroautophagy (GO:0016242) | 3.06041271 |
| 63 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.05679760 |
| 64 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.04133207 |
| 65 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.04133207 |
| 66 | interferon-gamma production (GO:0032609) | 3.02825199 |
| 67 | 7-methylguanosine mRNA capping (GO:0006370) | 3.02413312 |
| 68 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.02060488 |
| 69 | protein-cofactor linkage (GO:0018065) | 3.01638541 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.00357098 |
| 71 | mesonephros development (GO:0001823) | 2.99720213 |
| 72 | RNA capping (GO:0036260) | 2.98516132 |
| 73 | 7-methylguanosine RNA capping (GO:0009452) | 2.98516132 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96120167 |
| 75 | skin morphogenesis (GO:0043589) | 2.95563803 |
| 76 | cellular response to zinc ion (GO:0071294) | 2.94591907 |
| 77 | regulation of metalloenzyme activity (GO:0048552) | 2.94118061 |
| 78 | defense response to protozoan (GO:0042832) | 2.94020375 |
| 79 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.91976453 |
| 80 | adult feeding behavior (GO:0008343) | 2.90668569 |
| 81 | desmosome organization (GO:0002934) | 2.90473748 |
| 82 | nephron tubule formation (GO:0072079) | 2.90275436 |
| 83 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89516387 |
| 84 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.89332287 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89214879 |
| 86 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.87260815 |
| 87 | barbed-end actin filament capping (GO:0051016) | 2.86260065 |
| 88 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.84930923 |
| 89 | negative regulation of kidney development (GO:0090185) | 2.83302330 |
| 90 | ribosome assembly (GO:0042255) | 2.82327909 |
| 91 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.81824741 |
| 92 | DNA double-strand break processing (GO:0000729) | 2.80217319 |
| 93 | mast cell activation (GO:0045576) | 2.76028574 |
| 94 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.75504649 |
| 95 | establishment of viral latency (GO:0019043) | 2.74100603 |
| 96 | facial nerve structural organization (GO:0021612) | 2.73783379 |
| 97 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.73671401 |
| 98 | intermediate filament organization (GO:0045109) | 2.72651187 |
| 99 | positive regulation of ligase activity (GO:0051351) | 2.71979892 |
| 100 | cullin deneddylation (GO:0010388) | 2.71948578 |
| 101 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.71746495 |
| 102 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.71742214 |
| 103 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.71448382 |
| 104 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71192338 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.70882150 |
| 106 | galactose metabolic process (GO:0006012) | 2.70873110 |
| 107 | endothelial tube morphogenesis (GO:0061154) | 2.70305092 |
| 108 | morphogenesis of an endothelium (GO:0003159) | 2.70305092 |
| 109 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.70182723 |
| 110 | regulation of translational termination (GO:0006449) | 2.68824363 |
| 111 | protein localization to endosome (GO:0036010) | 2.68407320 |
| 112 | protein K6-linked ubiquitination (GO:0085020) | 2.66394291 |
| 113 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.65807598 |
| 114 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.65015172 |
| 115 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.64847499 |
| 116 | protein heterotetramerization (GO:0051290) | 2.63601792 |
| 117 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.63577895 |
| 118 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.63429239 |
| 119 | keratinocyte proliferation (GO:0043616) | 2.62944377 |
| 120 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.61802908 |
| 121 | opioid receptor signaling pathway (GO:0038003) | 2.61469750 |
| 122 | response to testosterone (GO:0033574) | 2.61357251 |
| 123 | centriole assembly (GO:0098534) | 2.60771512 |
| 124 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60548958 |
| 125 | negative regulation of ligase activity (GO:0051352) | 2.60548958 |
| 126 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.58760865 |
| 127 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.58588382 |
| 128 | platelet dense granule organization (GO:0060155) | 2.57910967 |
| 129 | polyamine biosynthetic process (GO:0006596) | 2.56803180 |
| 130 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.56674392 |
| 131 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.56674392 |
| 132 | protein hydroxylation (GO:0018126) | 2.56587204 |
| 133 | membrane raft organization (GO:0031579) | 2.56275484 |
| 134 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.55682440 |
| 135 | T cell receptor signaling pathway (GO:0050852) | 2.54499997 |
| 136 | lymphocyte costimulation (GO:0031294) | 2.53553939 |
| 137 | regulation of spindle organization (GO:0090224) | 2.53486974 |
| 138 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.53399410 |
| 139 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.52054462 |
| 140 | hypotonic response (GO:0006971) | 2.51541196 |
| 141 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.51513237 |
| 142 | regulation of mitotic spindle organization (GO:0060236) | 2.51298032 |
| 143 | central nervous system myelination (GO:0022010) | 2.51193556 |
| 144 | axon ensheathment in central nervous system (GO:0032291) | 2.51193556 |
| 145 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.51112662 |
| 146 | keratinocyte development (GO:0003334) | 2.50104717 |
| 147 | glomerulus development (GO:0032835) | 2.49201681 |
| 148 | keratinization (GO:0031424) | 2.47519296 |
| 149 | negative regulation of metanephros development (GO:0072217) | 2.47332574 |
| 150 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.46962690 |
| 151 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.44723764 |
| 152 | positive regulation of cell cycle arrest (GO:0071158) | 2.44601236 |
| 153 | regulation of axon regeneration (GO:0048679) | 2.43157225 |
| 154 | regulation of neuron projection regeneration (GO:0070570) | 2.43157225 |
| 155 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.42895229 |
| 156 | positive regulation of chemokine secretion (GO:0090197) | 2.42321994 |
| 157 | termination of RNA polymerase I transcription (GO:0006363) | 2.42106689 |
| 158 | T cell costimulation (GO:0031295) | 2.41624725 |
| 159 | response to protozoan (GO:0001562) | 2.41514009 |
| 160 | leukocyte aggregation (GO:0070486) | 2.41450385 |
| 161 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.41403527 |
| 162 | DNA dealkylation (GO:0035510) | 2.40503420 |
| 163 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.40492023 |
| 164 | transcription from RNA polymerase I promoter (GO:0006360) | 2.39726182 |
| 165 | ribosomal small subunit assembly (GO:0000028) | 2.39257116 |
| 166 | DNA deamination (GO:0045006) | 2.38478249 |
| 167 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.37336400 |
| 168 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.37328351 |
| 169 | peptidyl-arginine modification (GO:0018195) | 2.37147012 |
| 170 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.35570597 |
| 171 | melanosome organization (GO:0032438) | 2.35550668 |
| 172 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.33950595 |
| 173 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.33850767 |
| 174 | pigment granule organization (GO:0048753) | 2.33069542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 8.82130436 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.75161691 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.24913059 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.15987303 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.13220563 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.46941450 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.41440114 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.33335888 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29674025 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.14437378 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.96205745 |
| 12 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.85555629 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.69231912 |
| 14 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.67552531 |
| 15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.57235931 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.48802368 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.48408808 |
| 18 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.45564462 |
| 19 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.45564462 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.43427659 |
| 21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.22085144 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.15220343 |
| 23 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.13986617 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.09315535 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02458533 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.01543046 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00797532 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.96888018 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94680662 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94675576 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93541358 |
| 32 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.93496770 |
| 33 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.91114434 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.87051780 |
| 35 | ATF3_27146783_Chip-Seq_COLON_Human | 1.81972238 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77937700 |
| 37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.76216396 |
| 38 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.75765014 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.73680483 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.70617605 |
| 41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.70580800 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.70375017 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68550329 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67692172 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67012169 |
| 46 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.64842797 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.64125985 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64017030 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57853475 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.57258413 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57003440 |
| 52 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55931533 |
| 53 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.55841485 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53214416 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50918025 |
| 56 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50549935 |
| 57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50475810 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46466824 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45673070 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45005809 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43928380 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43122361 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43092687 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.42384683 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42376751 |
| 66 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42027938 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41759624 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40748644 |
| 69 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.40446247 |
| 70 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.39999411 |
| 71 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.39126709 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39040537 |
| 73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38923077 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38922358 |
| 75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38615845 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.37769192 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36914425 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.33564477 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33341563 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.32521684 |
| 81 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31590352 |
| 82 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30849903 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30725913 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29859347 |
| 85 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.29662345 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28972771 |
| 87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28962383 |
| 88 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24985770 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24917594 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.24556033 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24248923 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24123274 |
| 93 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.23937238 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23279855 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22367661 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21852214 |
| 97 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21829290 |
| 98 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21788011 |
| 99 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21662992 |
| 100 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21531187 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21154915 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20811552 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20305862 |
| 104 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.20087158 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19931971 |
| 106 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19912387 |
| 107 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19517863 |
| 108 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18790832 |
| 109 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.18786351 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18760600 |
| 111 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.18153431 |
| 112 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17291555 |
| 113 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16888114 |
| 114 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16875676 |
| 115 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16042228 |
| 116 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.15436355 |
| 117 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14507339 |
| 118 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12210915 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11854641 |
| 120 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11456168 |
| 121 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11265424 |
| 122 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11223299 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11009610 |
| 124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10884989 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10838498 |
| 126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10009223 |
| 127 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08564289 |
| 128 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.08122150 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07381291 |
| 130 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07196674 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07157639 |
| 132 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07109469 |
| 133 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.06087413 |
| 134 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.05862895 |
| 135 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05469148 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05320296 |
| 137 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05192105 |
| 138 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04806888 |
| 139 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04653545 |
| 140 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03853089 |
| 141 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.03762340 |
| 142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03397350 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03105875 |
| 144 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02980130 |
| 145 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02036711 |
| 146 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01830995 |
| 147 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01826034 |
| 148 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01548145 |
| 149 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01164211 |
| 150 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01045091 |
| 151 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99925147 |
| 152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99480168 |
| 153 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99308114 |
| 154 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98552837 |
| 155 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98381819 |
| 156 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.97597388 |
| 157 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97546132 |
| 158 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95949458 |
| 159 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95524376 |
| 160 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94197896 |
| 161 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94040624 |
| 162 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.93868069 |
| 163 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93520571 |
| 164 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93322884 |
| 165 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93217436 |
| 166 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93073376 |
| 167 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.92870837 |
| 168 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.92263649 |
| 169 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91623718 |
| 170 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91298754 |
| 171 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90184166 |
| 172 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90053883 |
| 173 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89721687 |
| 174 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.87402358 |
| 175 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84695332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.41157723 |
| 2 | MP0002098_abnormal_vibrissa_morphology | 3.39538348 |
| 3 | MP0005257_abnormal_intraocular_pressure | 3.19553595 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.04750494 |
| 5 | MP0003566_abnormal_cell_adhesion | 3.04124529 |
| 6 | MP0002095_abnormal_skin_pigmentation | 2.95393376 |
| 7 | MP0004272_abnormal_basement_membrane | 2.94787304 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.90428997 |
| 9 | MP0000579_abnormal_nail_morphology | 2.85779051 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.83584099 |
| 11 | MP0000383_abnormal_hair_follicle | 2.78529707 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.78275574 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.73889054 |
| 14 | MP0000749_muscle_degeneration | 2.71410092 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.58079676 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.54006144 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.50805335 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.41799610 |
| 19 | MP0000762_abnormal_tongue_morphology | 2.30259763 |
| 20 | MP0005671_abnormal_response_to | 2.29398002 |
| 21 | MP0002132_abnormal_respiratory_system | 2.28940215 |
| 22 | MP0004381_abnormal_hair_follicle | 2.19110865 |
| 23 | MP0000750_abnormal_muscle_regeneration | 2.17834382 |
| 24 | MP0010030_abnormal_orbit_morphology | 2.16134105 |
| 25 | MP0000647_abnormal_sebaceous_gland | 2.14132465 |
| 26 | MP0000427_abnormal_hair_cycle | 2.09906242 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 2.02679027 |
| 28 | MP0005083_abnormal_biliary_tract | 2.00805489 |
| 29 | MP0005310_abnormal_salivary_gland | 2.00556747 |
| 30 | MP0002060_abnormal_skin_morphology | 1.96787745 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.94389998 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.88612613 |
| 33 | MP0005023_abnormal_wound_healing | 1.87662978 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.85758534 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.82224748 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.80832419 |
| 37 | MP0001529_abnormal_vocalization | 1.76829160 |
| 38 | MP0000751_myopathy | 1.74365005 |
| 39 | MP0000534_abnormal_ureter_morphology | 1.73577233 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.72575490 |
| 41 | MP0005451_abnormal_body_composition | 1.72224609 |
| 42 | MP0003880_abnormal_central_pattern | 1.72028700 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.71996871 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.71108299 |
| 45 | MP0003786_premature_aging | 1.69464938 |
| 46 | MP0003091_abnormal_cell_migration | 1.67430551 |
| 47 | MP0003787_abnormal_imprinting | 1.65912097 |
| 48 | MP0000537_abnormal_urethra_morphology | 1.61681428 |
| 49 | MP0000733_abnormal_muscle_development | 1.61456919 |
| 50 | MP0009840_abnormal_foam_cell | 1.60323130 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.59713426 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.59692668 |
| 53 | MP0001851_eye_inflammation | 1.59549629 |
| 54 | MP0010678_abnormal_skin_adnexa | 1.58952189 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.58170488 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 1.57704493 |
| 57 | MP0005197_abnormal_uvea_morphology | 1.54915330 |
| 58 | MP0005165_increased_susceptibility_to | 1.54138179 |
| 59 | MP0000377_abnormal_hair_follicle | 1.52615850 |
| 60 | MP0005409_darkened_coat_color | 1.52552118 |
| 61 | MP0004885_abnormal_endolymph | 1.50971371 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.49479160 |
| 63 | MP0002933_joint_inflammation | 1.49295265 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.48633091 |
| 65 | MP0009053_abnormal_anal_canal | 1.48034928 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.47928598 |
| 67 | MP0003123_paternal_imprinting | 1.46777987 |
| 68 | MP0005025_abnormal_response_to | 1.46776165 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.46681039 |
| 70 | MP0004233_abnormal_muscle_weight | 1.45906271 |
| 71 | MP0000747_muscle_weakness | 1.42481138 |
| 72 | MP0002736_abnormal_nociception_after | 1.41741883 |
| 73 | MP0005499_abnormal_olfactory_system | 1.41670168 |
| 74 | MP0005394_taste/olfaction_phenotype | 1.41670168 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.41317737 |
| 76 | MP0000920_abnormal_myelination | 1.38589097 |
| 77 | MP0005275_abnormal_skin_tensile | 1.37857235 |
| 78 | MP0009785_altered_susceptibility_to | 1.37580705 |
| 79 | MP0002420_abnormal_adaptive_immunity | 1.37202846 |
| 80 | MP0000759_abnormal_skeletal_muscle | 1.36199584 |
| 81 | MP0003011_delayed_dark_adaptation | 1.36077470 |
| 82 | MP0003315_abnormal_perineum_morphology | 1.36022355 |
| 83 | MP0002163_abnormal_gland_morphology | 1.35024995 |
| 84 | MP0000858_altered_metastatic_potential | 1.33106996 |
| 85 | MP0001819_abnormal_immune_cell | 1.32886582 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 1.30113718 |
| 87 | MP0002269_muscular_atrophy | 1.29688699 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 1.29619336 |
| 89 | MP0001905_abnormal_dopamine_level | 1.27508079 |
| 90 | MP0004742_abnormal_vestibular_system | 1.26561428 |
| 91 | MP0002723_abnormal_immune_serum | 1.26412715 |
| 92 | MP0005171_absent_coat_pigmentation | 1.22622998 |
| 93 | MP0004510_myositis | 1.22406925 |
| 94 | MP0009697_abnormal_copulation | 1.21448502 |
| 95 | MP0008007_abnormal_cellular_replicative | 1.19609663 |
| 96 | MP0002638_abnormal_pupillary_reflex | 1.18063979 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 1.17847258 |
| 98 | MP0005501_abnormal_skin_physiology | 1.17577263 |
| 99 | MP0002796_impaired_skin_barrier | 1.15863011 |
| 100 | MP0003300_gastrointestinal_ulcer | 1.14607124 |
| 101 | MP0001800_abnormal_humoral_immune | 1.14176026 |
| 102 | MP0002009_preneoplasia | 1.12447644 |
| 103 | MP0002938_white_spotting | 1.11010714 |
| 104 | MP0000343_altered_response_to | 1.09527870 |
| 105 | MP0001968_abnormal_touch/_nociception | 1.09464326 |
| 106 | MP0003077_abnormal_cell_cycle | 1.08723530 |
| 107 | MP0001790_abnormal_immune_system | 1.07932195 |
| 108 | MP0005387_immune_system_phenotype | 1.07932195 |
| 109 | MP0005670_abnormal_white_adipose | 1.07272236 |
| 110 | MP0001188_hyperpigmentation | 1.06962808 |
| 111 | MP0003950_abnormal_plasma_membrane | 1.06524089 |
| 112 | MP0003942_abnormal_urinary_system | 1.06106525 |
| 113 | MP0005623_abnormal_meninges_morphology | 1.05034769 |
| 114 | MP0008260_abnormal_autophagy | 1.04481683 |
| 115 | MP0002398_abnormal_bone_marrow | 1.03693042 |
| 116 | MP0000367_abnormal_coat/_hair | 1.02823180 |
| 117 | MP0001661_extended_life_span | 1.02585267 |
| 118 | MP0000358_abnormal_cell_content/ | 1.01204335 |
| 119 | MP0002452_abnormal_antigen_presenting | 0.99865538 |
| 120 | MP0002282_abnormal_trachea_morphology | 0.98463182 |
| 121 | MP0005330_cardiomyopathy | 0.96670910 |
| 122 | MP0000716_abnormal_immune_system | 0.95898888 |
| 123 | MP0010234_abnormal_vibrissa_follicle | 0.95602920 |
| 124 | MP0005164_abnormal_response_to | 0.94540522 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.94510976 |
| 126 | MP0000350_abnormal_cell_proliferation | 0.94278891 |
| 127 | MP0008058_abnormal_DNA_repair | 0.93750226 |
| 128 | MP0004947_skin_inflammation | 0.93214009 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92803771 |
| 130 | MP0001542_abnormal_bone_strength | 0.92114352 |
| 131 | MP0001216_abnormal_epidermal_layer | 0.92017463 |
| 132 | MP0000371_diluted_coat_color | 0.91812209 |
| 133 | MP0002177_abnormal_outer_ear | 0.90605297 |
| 134 | MP0004858_abnormal_nervous_system | 0.90255539 |
| 135 | MP0005408_hypopigmentation | 0.89800211 |
| 136 | MP0001340_abnormal_eyelid_morphology | 0.88922488 |
| 137 | MP0010352_gastrointestinal_tract_polyps | 0.88627307 |
| 138 | MP0001243_abnormal_dermal_layer | 0.88511015 |
| 139 | MP0002734_abnormal_mechanical_nocicepti | 0.87299046 |
| 140 | MP0003279_aneurysm | 0.84480047 |
| 141 | MP0002419_abnormal_innate_immunity | 0.84182565 |
| 142 | MP0000778_abnormal_nervous_system | 0.82652924 |
| 143 | MP0000678_abnormal_parathyroid_gland | 0.82625703 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.82465556 |
| 145 | MP0005193_abnormal_anterior_eye | 0.81887060 |
| 146 | MP0003755_abnormal_palate_morphology | 0.81328517 |
| 147 | MP0010771_integument_phenotype | 0.80477718 |
| 148 | MP0000372_irregular_coat_pigmentation | 0.80298962 |
| 149 | MP0000516_abnormal_urinary_system | 0.79770938 |
| 150 | MP0005367_renal/urinary_system_phenotyp | 0.79770938 |
| 151 | MP0002006_tumorigenesis | 0.78703462 |
| 152 | MP0005166_decreased_susceptibility_to | 0.78451659 |
| 153 | MP0001186_pigmentation_phenotype | 0.78197804 |
| 154 | MP0004087_abnormal_muscle_fiber | 0.77283988 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.76423677 |
| 156 | MP0001970_abnormal_pain_threshold | 0.76421694 |
| 157 | MP0000627_abnormal_mammary_gland | 0.75777605 |
| 158 | MP0005084_abnormal_gallbladder_morpholo | 0.75172963 |
| 159 | MP0008932_abnormal_embryonic_tissue | 0.74800833 |
| 160 | MP0003186_abnormal_redox_activity | 0.74158249 |
| 161 | MP0002295_abnormal_pulmonary_circulatio | 0.73433725 |
| 162 | MP0001348_abnormal_lacrimal_gland | 0.73215695 |
| 163 | MP0001849_ear_inflammation | 0.71745968 |
| 164 | MP0002064_seizures | 0.71467480 |
| 165 | MP0000703_abnormal_thymus_morphology | 0.70513589 |
| 166 | MP0001324_abnormal_eye_pigmentation | 0.70093546 |
| 167 | MP0001915_intracranial_hemorrhage | 0.69995219 |
| 168 | MP0000685_abnormal_immune_system | 0.69718294 |
| 169 | MP0009250_abnormal_appendicular_skeleto | 0.69647205 |
| 170 | MP0002972_abnormal_cardiac_muscle | 0.69347823 |
| 171 | MP0008057_abnormal_DNA_replication | 0.69198331 |
| 172 | MP0001764_abnormal_homeostasis | 0.69179701 |
| 173 | MP0003075_altered_response_to | 0.69117391 |
| 174 | MP0000689_abnormal_spleen_morphology | 0.68724940 |
| 175 | MP0000003_abnormal_adipose_tissue | 0.65946755 |
| 176 | MP0000163_abnormal_cartilage_morphology | 0.63976625 |
| 177 | MP0009931_abnormal_skin_appearance | 0.63900754 |
| 178 | MP0002085_abnormal_embryonic_tissue | 0.63519734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.72072451 |
| 2 | Woolly hair (HP:0002224) | 4.02159096 |
| 3 | Short nail (HP:0001799) | 3.83886459 |
| 4 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.81354034 |
| 5 | Atrophic scars (HP:0001075) | 3.76464011 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.69724784 |
| 7 | Keratoconjunctivitis sicca (HP:0001097) | 3.49282182 |
| 8 | Slow-growing hair (HP:0002217) | 3.48835185 |
| 9 | Abnormality of hair growth rate (HP:0011363) | 3.48835185 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.47339710 |
| 11 | Hypotrichosis (HP:0001006) | 3.41386400 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 3.33442696 |
| 13 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.33442696 |
| 14 | Palpebral edema (HP:0100540) | 3.30754136 |
| 15 | Parakeratosis (HP:0001036) | 3.18861357 |
| 16 | Abnormality of cochlea (HP:0000375) | 3.15723049 |
| 17 | Spondylolisthesis (HP:0003302) | 3.15534758 |
| 18 | Prominent metopic ridge (HP:0005487) | 3.12615436 |
| 19 | Keratoconjunctivitis (HP:0001096) | 3.12197908 |
| 20 | Brittle hair (HP:0002299) | 3.08568997 |
| 21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.07728096 |
| 22 | Fibular aplasia (HP:0002990) | 3.04824162 |
| 23 | Broad face (HP:0000283) | 3.03988447 |
| 24 | Erythema (HP:0010783) | 3.02842092 |
| 25 | Microglossia (HP:0000171) | 3.02718000 |
| 26 | Fragile nails (HP:0001808) | 3.00004003 |
| 27 | Spinal cord lesions (HP:0100561) | 2.90455714 |
| 28 | Syringomyelia (HP:0003396) | 2.90455714 |
| 29 | Oral leukoplakia (HP:0002745) | 2.89994486 |
| 30 | Papilledema (HP:0001085) | 2.85594874 |
| 31 | Pili torti (HP:0003777) | 2.81444159 |
| 32 | Short clavicles (HP:0000894) | 2.79872266 |
| 33 | Abnormality of the metopic suture (HP:0005556) | 2.76588977 |
| 34 | Colon cancer (HP:0003003) | 2.75603303 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.75126124 |
| 36 | Optic neuritis (HP:0100653) | 2.75126124 |
| 37 | Hypoplasia of the thymus (HP:0000778) | 2.73450839 |
| 38 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.71650771 |
| 39 | Optic nerve coloboma (HP:0000588) | 2.71360315 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.71326135 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.69708880 |
| 42 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.68375416 |
| 43 | Glucose intolerance (HP:0000833) | 2.68065140 |
| 44 | Mitochondrial inheritance (HP:0001427) | 2.67724018 |
| 45 | Renal Fanconi syndrome (HP:0001994) | 2.64446645 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.64290262 |
| 47 | Alopecia of scalp (HP:0002293) | 2.60361526 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.59178637 |
| 49 | Morphological abnormality of the inner ear (HP:0011390) | 2.58583636 |
| 50 | Abnormality of the frontal sinuses (HP:0002687) | 2.56036566 |
| 51 | Rough bone trabeculation (HP:0100670) | 2.55917093 |
| 52 | Bifid uvula (HP:0000193) | 2.54156522 |
| 53 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 2.53998949 |
| 54 | Delayed gross motor development (HP:0002194) | 2.53910335 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.50240624 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48173014 |
| 57 | Gangrene (HP:0100758) | 2.47533534 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.46615251 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.44103229 |
| 60 | Abnormality of the parietal bone (HP:0002696) | 2.42825691 |
| 61 | Trismus (HP:0000211) | 2.41745260 |
| 62 | Asplenia (HP:0001746) | 2.41662347 |
| 63 | Follicular hyperkeratosis (HP:0007502) | 2.41001971 |
| 64 | Cerebral hypomyelination (HP:0006808) | 2.40785416 |
| 65 | Trigonocephaly (HP:0000243) | 2.39290037 |
| 66 | Widely patent fontanelles and sutures (HP:0004492) | 2.38918383 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38227045 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38227045 |
| 69 | Congenital, generalized hypertrichosis (HP:0004540) | 2.37802760 |
| 70 | Flattened epiphyses (HP:0003071) | 2.37120731 |
| 71 | Leukodystrophy (HP:0002415) | 2.34568940 |
| 72 | Birth length less than 3rd percentile (HP:0003561) | 2.33207888 |
| 73 | Lissencephaly (HP:0001339) | 2.32874291 |
| 74 | Thyroid-stimulating hormone excess (HP:0002925) | 2.32559148 |
| 75 | Selective tooth agenesis (HP:0001592) | 2.32326085 |
| 76 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.32233780 |
| 77 | Heterochromia iridis (HP:0001100) | 2.31513284 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.30816165 |
| 79 | Cholecystitis (HP:0001082) | 2.30816165 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.30101123 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.29525371 |
| 82 | Sparse eyelashes (HP:0000653) | 2.29054142 |
| 83 | Acute encephalopathy (HP:0006846) | 2.28545679 |
| 84 | Adrenal hypoplasia (HP:0000835) | 2.27150420 |
| 85 | Nemaline bodies (HP:0003798) | 2.25375853 |
| 86 | Abnormal protein glycosylation (HP:0012346) | 2.23434512 |
| 87 | Abnormal glycosylation (HP:0012345) | 2.23434512 |
| 88 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.23434512 |
| 89 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.23434512 |
| 90 | Focal motor seizures (HP:0011153) | 2.22710693 |
| 91 | Hypoplasia of the uterus (HP:0000013) | 2.20442014 |
| 92 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.20274397 |
| 93 | Abnormal hair laboratory examination (HP:0003328) | 2.19716579 |
| 94 | Neck muscle weakness (HP:0000467) | 2.18200716 |
| 95 | Milia (HP:0001056) | 2.16499570 |
| 96 | Increased CSF lactate (HP:0002490) | 2.15989577 |
| 97 | Poor head control (HP:0002421) | 2.14309204 |
| 98 | Neuroendocrine neoplasm (HP:0100634) | 2.12530558 |
| 99 | Pulmonary fibrosis (HP:0002206) | 2.11263558 |
| 100 | Natal tooth (HP:0000695) | 2.11181152 |
| 101 | Bradycardia (HP:0001662) | 2.11134195 |
| 102 | Vascular calcification (HP:0004934) | 2.10301579 |
| 103 | Reticulocytopenia (HP:0001896) | 2.09623633 |
| 104 | Abnormal number of erythroid precursors (HP:0012131) | 2.08542932 |
| 105 | Retinal dysplasia (HP:0007973) | 2.08165071 |
| 106 | Thick nail (HP:0001805) | 2.08024247 |
| 107 | Renal cortical cysts (HP:0000803) | 2.07132845 |
| 108 | Radial bowing (HP:0002986) | 2.05586466 |
| 109 | Abnormal hair whorl (HP:0010721) | 2.05251480 |
| 110 | Acanthosis nigricans (HP:0000956) | 2.05090381 |
| 111 | T lymphocytopenia (HP:0005403) | 2.01863629 |
| 112 | Exertional dyspnea (HP:0002875) | 2.01540482 |
| 113 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00981022 |
| 114 | Duplicated collecting system (HP:0000081) | 1.99986736 |
| 115 | Amyloidosis (HP:0011034) | 1.99858409 |
| 116 | Aortic dissection (HP:0002647) | 1.99387881 |
| 117 | IgM deficiency (HP:0002850) | 1.99260665 |
| 118 | Albinism (HP:0001022) | 1.99204089 |
| 119 | Myositis (HP:0100614) | 1.98658753 |
| 120 | Basal ganglia calcification (HP:0002135) | 1.98174535 |
| 121 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.98163258 |
| 122 | Increased connective tissue (HP:0009025) | 1.97277062 |
| 123 | Hepatocellular necrosis (HP:0001404) | 1.97252020 |
| 124 | Multiple lipomas (HP:0001012) | 1.96911120 |
| 125 | Melanoma (HP:0002861) | 1.95921501 |
| 126 | Ileus (HP:0002595) | 1.95053420 |
| 127 | Entropion (HP:0000621) | 1.94584268 |
| 128 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.94556354 |
| 129 | Reduced antithrombin III activity (HP:0001976) | 1.94431209 |
| 130 | Wormian bones (HP:0002645) | 1.93319757 |
| 131 | Nail dystrophy (HP:0008404) | 1.92864369 |
| 132 | Orchitis (HP:0100796) | 1.92777865 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.92477248 |
| 134 | IgG deficiency (HP:0004315) | 1.92142696 |
| 135 | Right ventricular cardiomyopathy (HP:0011663) | 1.91935550 |
| 136 | Generalized hypopigmentation (HP:0007513) | 1.91091428 |
| 137 | Hydroureter (HP:0000072) | 1.91067622 |
| 138 | Tetraparesis (HP:0002273) | 1.91067363 |
| 139 | Type 2 muscle fiber atrophy (HP:0003554) | 1.90171434 |
| 140 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89888567 |
| 141 | Abnormality of the umbilical cord (HP:0010881) | 1.89872922 |
| 142 | Eczematoid dermatitis (HP:0000976) | 1.88598102 |
| 143 | Interstitial pulmonary disease (HP:0006530) | 1.88409251 |
| 144 | Renal tubular acidosis (HP:0001947) | 1.87082687 |
| 145 | Testicular atrophy (HP:0000029) | 1.85870694 |
| 146 | Agnosia (HP:0010524) | 1.85848538 |
| 147 | Lipid accumulation in hepatocytes (HP:0006561) | 1.84999950 |
| 148 | Mitral stenosis (HP:0001718) | 1.83417076 |
| 149 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82149598 |
| 150 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82149598 |
| 151 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82149598 |
| 152 | Neurofibrillary tangles (HP:0002185) | 1.81891305 |
| 153 | Stomach cancer (HP:0012126) | 1.81857411 |
| 154 | Flat occiput (HP:0005469) | 1.81836238 |
| 155 | Nasolacrimal duct obstruction (HP:0000579) | 1.81421946 |
| 156 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80433838 |
| 157 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80360989 |
| 158 | Abnormality of renal resorption (HP:0011038) | 1.80042098 |
| 159 | Keratitis (HP:0000491) | 1.79914521 |
| 160 | Abnormality of T cell number (HP:0011839) | 1.79814430 |
| 161 | Conjunctival hamartoma (HP:0100780) | 1.79468504 |
| 162 | Insulin resistance (HP:0000855) | 1.76846579 |
| 163 | Abnormality of the renal collecting system (HP:0004742) | 1.76430430 |
| 164 | Sensory axonal neuropathy (HP:0003390) | 1.76211505 |
| 165 | Arterial tortuosity (HP:0005116) | 1.76145805 |
| 166 | Chronic otitis media (HP:0000389) | 1.75719465 |
| 167 | Abnormality of the aortic arch (HP:0012303) | 1.75427608 |
| 168 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75262473 |
| 169 | Obstructive lung disease (HP:0006536) | 1.75262473 |
| 170 | Panhypogammaglobulinemia (HP:0003139) | 1.74866329 |
| 171 | Erythroderma (HP:0001019) | 1.73718816 |
| 172 | Deviation of the thumb (HP:0009603) | 1.73451334 |
| 173 | Prolonged neonatal jaundice (HP:0006579) | 1.72695464 |
| 174 | Bowing of the arm (HP:0006488) | 1.72555346 |
| 175 | Bowed forearm bones (HP:0003956) | 1.72555346 |
| 176 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.71960965 |
| 177 | Abnormal trabecular bone morphology (HP:0100671) | 1.70793028 |
| 178 | Exercise intolerance (HP:0003546) | 1.70734580 |
| 179 | Difficulty climbing stairs (HP:0003551) | 1.70689002 |
| 180 | Onycholysis (HP:0001806) | 1.70288604 |
| 181 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.67955914 |
| 182 | Elbow flexion contracture (HP:0002987) | 1.65792056 |
| 183 | Muscle fiber inclusion bodies (HP:0100299) | 1.65321764 |
| 184 | Poor speech (HP:0002465) | 1.64489617 |
| 185 | Beaking of vertebral bodies (HP:0004568) | 1.63237413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.54774487 |
| 2 | TXK | 3.42855352 |
| 3 | VRK2 | 3.33282233 |
| 4 | MAP3K12 | 3.26527565 |
| 5 | IRAK1 | 2.98742389 |
| 6 | NME2 | 2.88176062 |
| 7 | LMTK2 | 2.75408878 |
| 8 | SIK3 | 2.47521008 |
| 9 | DYRK2 | 2.43237946 |
| 10 | ARAF | 2.32324812 |
| 11 | EPHB2 | 2.27787023 |
| 12 | IRAK4 | 2.25565141 |
| 13 | BLK | 2.23795132 |
| 14 | CLK1 | 2.12702848 |
| 15 | EPHA3 | 2.08468871 |
| 16 | IRAK2 | 2.06131909 |
| 17 | BMPR2 | 1.90713773 |
| 18 | PBK | 1.87458790 |
| 19 | PAK4 | 1.82977367 |
| 20 | DYRK3 | 1.81544636 |
| 21 | MST4 | 1.76745571 |
| 22 | VRK1 | 1.75778990 |
| 23 | IRAK3 | 1.74546650 |
| 24 | SRPK1 | 1.73565143 |
| 25 | ERBB3 | 1.70131251 |
| 26 | PTK2 | 1.69287925 |
| 27 | LIMK1 | 1.69007670 |
| 28 | MAP3K3 | 1.66938742 |
| 29 | MARK1 | 1.65830454 |
| 30 | ERBB4 | 1.54480153 |
| 31 | MOS | 1.52402622 |
| 32 | EPHB1 | 1.50581520 |
| 33 | MET | 1.49833494 |
| 34 | MAPK13 | 1.48498344 |
| 35 | ABL2 | 1.46876449 |
| 36 | DAPK3 | 1.44759490 |
| 37 | BUB1 | 1.40740232 |
| 38 | PNCK | 1.34407510 |
| 39 | PHKG2 | 1.30546924 |
| 40 | PHKG1 | 1.30546924 |
| 41 | STK10 | 1.29982048 |
| 42 | ERN1 | 1.29014189 |
| 43 | FES | 1.27065023 |
| 44 | SCYL2 | 1.26856089 |
| 45 | NLK | 1.24777330 |
| 46 | UHMK1 | 1.22950491 |
| 47 | MAP4K1 | 1.21542293 |
| 48 | LATS2 | 1.19934971 |
| 49 | EIF2AK1 | 1.19100312 |
| 50 | CCNB1 | 1.18807610 |
| 51 | CSNK1G3 | 1.17927703 |
| 52 | PRKG2 | 1.17417740 |
| 53 | CASK | 1.16303286 |
| 54 | YES1 | 1.09547464 |
| 55 | TESK1 | 1.08725952 |
| 56 | MAP2K6 | 1.06860884 |
| 57 | MAP3K14 | 1.05623776 |
| 58 | CSNK1G1 | 1.04832944 |
| 59 | STK16 | 1.04544220 |
| 60 | MST1R | 1.04486853 |
| 61 | SIK1 | 1.02819086 |
| 62 | CDK8 | 1.00459108 |
| 63 | TESK2 | 0.98240097 |
| 64 | TAOK2 | 0.91833795 |
| 65 | ZAP70 | 0.88454778 |
| 66 | OXSR1 | 0.86835164 |
| 67 | CDK19 | 0.86599522 |
| 68 | MYLK | 0.86449468 |
| 69 | MUSK | 0.84976534 |
| 70 | EIF2AK2 | 0.83338826 |
| 71 | TLK1 | 0.83099282 |
| 72 | LCK | 0.82929432 |
| 73 | MKNK1 | 0.78777315 |
| 74 | NEK6 | 0.76306325 |
| 75 | SMG1 | 0.75765685 |
| 76 | SYK | 0.75579737 |
| 77 | ZAK | 0.74084795 |
| 78 | CSNK1G2 | 0.72543639 |
| 79 | LRRK2 | 0.71530024 |
| 80 | TBK1 | 0.71116901 |
| 81 | BCR | 0.70086406 |
| 82 | BCKDK | 0.70024993 |
| 83 | PRKD3 | 0.69366073 |
| 84 | FGFR4 | 0.66283902 |
| 85 | STK38 | 0.66235482 |
| 86 | CSNK1A1L | 0.65679222 |
| 87 | MAP3K5 | 0.65656437 |
| 88 | DYRK1A | 0.64923121 |
| 89 | ROCK2 | 0.64043096 |
| 90 | ILK | 0.63890157 |
| 91 | ERBB2 | 0.63703468 |
| 92 | FER | 0.63062411 |
| 93 | CAMK2G | 0.62599326 |
| 94 | FGFR1 | 0.61125351 |
| 95 | MINK1 | 0.60862144 |
| 96 | HCK | 0.60382204 |
| 97 | TRPM7 | 0.59409313 |
| 98 | PAK1 | 0.59258748 |
| 99 | LYN | 0.58175665 |
| 100 | MAP3K2 | 0.56112801 |
| 101 | HIPK2 | 0.55621578 |
| 102 | PRKCQ | 0.55511262 |
| 103 | BRAF | 0.55054795 |
| 104 | MAPKAPK3 | 0.54609800 |
| 105 | PLK4 | 0.54472667 |
| 106 | PRKCI | 0.54264795 |
| 107 | GRK7 | 0.53715941 |
| 108 | CDK18 | 0.53363340 |
| 109 | PTK2B | 0.52350742 |
| 110 | PIM2 | 0.50905703 |
| 111 | CAMK2B | 0.50657608 |
| 112 | CDK7 | 0.49442416 |
| 113 | NEK9 | 0.48315845 |
| 114 | ROCK1 | 0.48229416 |
| 115 | ITK | 0.47874276 |
| 116 | PAK6 | 0.47052021 |
| 117 | MAPKAPK2 | 0.45657458 |
| 118 | MAP3K8 | 0.45050407 |
| 119 | PAK2 | 0.44727293 |
| 120 | PRKCD | 0.44412546 |
| 121 | NTRK1 | 0.43304119 |
| 122 | AURKA | 0.43014021 |
| 123 | MAP2K7 | 0.42859091 |
| 124 | KDR | 0.42825399 |
| 125 | NTRK3 | 0.42798315 |
| 126 | STK38L | 0.42788703 |
| 127 | MAPK4 | 0.41923486 |
| 128 | NEK1 | 0.41727443 |
| 129 | CDK15 | 0.41626548 |
| 130 | MAP3K11 | 0.41185076 |
| 131 | TGFBR2 | 0.40573792 |
| 132 | DAPK1 | 0.39996993 |
| 133 | RPS6KA5 | 0.39692268 |
| 134 | PLK2 | 0.39473455 |
| 135 | BRSK1 | 0.39281759 |
| 136 | IKBKE | 0.39207093 |
| 137 | CSNK1A1 | 0.38710688 |
| 138 | CSNK2A1 | 0.38692398 |
| 139 | CSK | 0.37979326 |
| 140 | CDK11A | 0.37866087 |
| 141 | ATR | 0.36823925 |
| 142 | PASK | 0.35898472 |
| 143 | EIF2AK3 | 0.35842555 |
| 144 | CDC7 | 0.34750366 |
| 145 | PTK6 | 0.34241503 |
| 146 | FLT3 | 0.32520937 |
| 147 | GSK3A | 0.31507451 |
| 148 | AURKB | 0.30071248 |
| 149 | TTN | 0.30045006 |
| 150 | PLK1 | 0.28010994 |
| 151 | STK4 | 0.27793702 |
| 152 | PRKCE | 0.27313011 |
| 153 | MAP2K3 | 0.26840850 |
| 154 | CDK9 | 0.25368810 |
| 155 | AKT2 | 0.25331557 |
| 156 | ADRBK1 | 0.25050050 |
| 157 | CHEK2 | 0.24182975 |
| 158 | MTOR | 0.22294978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.76601619 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.56768876 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.87944565 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.83047515 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.83004822 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.80042101 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.66774584 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.41277609 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.20325273 |
| 10 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.15978479 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.14517044 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09103231 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.06704826 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.97753998 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.97480778 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.90317283 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.88921591 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.87804986 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86556260 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84409641 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.84227666 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.83517990 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.83243024 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78646699 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75055738 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72221473 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.72194613 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.70534787 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.70532670 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.70040726 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.56432973 |
| 32 | Tight junction_Homo sapiens_hsa04530 | 1.51897382 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.50682840 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.50471257 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49592721 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48204803 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41173362 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.40273718 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.38790354 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.38786473 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36710146 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32794736 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.30933505 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29423170 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27731188 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25665903 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24901844 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 1.21123439 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15641488 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.07713589 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 1.05724115 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04211767 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03771386 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02234300 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00835607 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99274109 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98849024 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98790541 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98248114 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97347124 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.96998541 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.96863615 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96355896 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94925499 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93915117 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93780535 |
| 67 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.90277945 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.85078999 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83970670 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.81473076 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81164115 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80203750 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.79430004 |
| 74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.77943296 |
| 75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77327305 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74846416 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.74731768 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.71724204 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71073668 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.71049296 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.69602227 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68297621 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67903027 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67379750 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66413604 |
| 86 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66388530 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66340086 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65409160 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64816169 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.63794669 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62403593 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61735667 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.61257313 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61197878 |
| 95 | RNA transport_Homo sapiens_hsa03013 | 0.60143709 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59025817 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58320540 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56550292 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56530343 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.55893063 |
| 101 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55815275 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55470207 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54654361 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54641224 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54590415 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54575879 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53843860 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53585641 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.52841049 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52138927 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.50597719 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49630351 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49051842 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47908716 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.47275296 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46632074 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46240127 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46062200 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45945848 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45568472 |
| 121 | Cell cycle_Homo sapiens_hsa04110 | 0.45521295 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45120459 |
| 123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45092921 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43505161 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43446659 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43254802 |
| 127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42783624 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42431301 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41662716 |
| 130 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41396375 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40295577 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40196932 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40098094 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.40067018 |
| 135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40049750 |
| 136 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39654384 |
| 137 | Prostate cancer_Homo sapiens_hsa05215 | 0.39583757 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39036050 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37815077 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37677493 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37327231 |
| 142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37023890 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.36851112 |
| 144 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36337795 |
| 145 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35939738 |
| 146 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35925785 |
| 147 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35500576 |
| 148 | Taste transduction_Homo sapiens_hsa04742 | 0.35477341 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.35407585 |
| 150 | Adherens junction_Homo sapiens_hsa04520 | 0.35093894 |
| 151 | Apoptosis_Homo sapiens_hsa04210 | 0.34667827 |
| 152 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29976017 |
| 153 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29533422 |
| 154 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25341862 |
| 155 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25218110 |
| 156 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25213272 |
| 157 | Tuberculosis_Homo sapiens_hsa05152 | 0.24121536 |
| 158 | Lysosome_Homo sapiens_hsa04142 | 0.23638023 |
| 159 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23567561 |
| 160 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.23564754 |

